Skip to main content
. 2021 Mar 24;8:629874. doi: 10.3389/fmolb.2021.629874

FIGURE 3.

FIGURE 3

Inhibitors of cytoskeletal organization pathways (calpeptin, Y27632, NSC23766, cytochalasin D, and chloramidine/Cl-amidine) inhibit EV release through intracellular trafficking and budding of the vesicles.